During the past decade, Thananda Trakarnvanich conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Thananda Trakarnvanich" are "Covid19" (1 trials), "Effect of Drug" (1 trials), "Immunogenicity" (1 trials), "Ivermectin Poisoning" (1 trials) and "SARS-CoV2 Infection" (1 trials). Many other conditions were trialed in "Thananda Trakarnvanich" in a lesser frequency.

Most popular intervention types in "Thananda Trakarnvanich" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Immunogenicity after first dose of participants who received first dose of ChAdox-1 n COV-19 vaccine" (1 trials), "Ivermectin" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Thananda Trakarnvanich" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Thananda Trakarnvanich". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Thananda Trakarnvanich, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Thananda Trakarnvanich, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".